Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21248785 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
Condition: Hypertension
Interventions: Drug: Valsartan + amlodipine;   Drug: Valsartan + HCTZ;   Drug: Amlodipine + HCTZ;   Drug: Valsartan + amlodipine + HCTZ

Indicates status has not been verified in more than two years